HCA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $432.20
Capitalizzazione di Mercato (MRQ) $94.20B
P/E (TTM) 14.5
EPS (TTM) $29.82
Ricavi (TTM) $78.01B
Rendimento div. 0.70%
ROE (TTM) -124.0%
D/E Debito/Patrimonio (MRQ) -6.5
Intervallo 52 sett. $354–$557

HCA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su HCA Healthcare, Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti230.000 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi$75.60B
2016-12-31 → 2025-12-31
EPS$28.33
2016-12-31 → 2025-12-31
Flusso di cassa libero$7.69B
2016-12-31 → 2025-12-31
Margine netto8.8%
2018-12-31 → 2025-12-31
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica Tendenza 5 anni HCA media 5 anni Mediana dei peer Verdetto
P/E (TTM) 14.5media 5 anni ≈13.8 ≈13.8 16.5 Sottovalutato
P/S (TTM) 1.2media 5 anni ≈1.2 ≈1.2 1.3 Sottovalutato
P/B (MRQ) -14.2media 5 anni ≈-39.2 ≈-39.2 · ·
EV / EBITDA 39.1media 5 anni ≈37.3 ≈37.3 19.6 Sopravvalutato
Prezzo / FCF (TTM) 15.7media 5 anni ≈14.6 ≈14.6 · ·
Prezzo / Flusso di cassa (TTM) 8.5media 5 anni ≈7.9 ≈7.9 9.7 Sottovalutato
EV / Revenue (EV / Ricavi) 1.8media 5 anni ≈1.8 ≈1.8 · ·
EV / FCF 17.9media 5 anni ≈21.8 ≈21.8 · ·
PEG Ratio ≈0.7 · · ·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

13
Dividend Yield0.70%
Rapporto di Distribuzione Utili10.0%
Pagamento annualizzato≈$3.12Pagato trimestralmente
CAGR Dividendi 5Y≈21.9%Per azione, rettificato per lo split
Striscia di crescita≈5Anni consecutivi di crescita dei dividendi
Data ex-dividendoImportoValutaRendimento
Set 16, 2026$0,78USD≈0.71%
Giu 16, 2026$0,78USD≈0.76%
Mar 17, 2026$0,78USD≈0.58%
Dic 15, 2025$0,72USD≈0.60%
Set 16, 2025$0,72USD≈0.71%
Giu 16, 2025$0,72USD≈0.75%
Mar 17, 2025$0,72USD≈0.82%
Dic 13, 2024$0,66USD≈0.84%
Set 16, 2024$0,66USD≈0.64%
Giu 14, 2024$0,66USD≈0.75%
Mar 14, 2024$0,66USD≈0.76%
Dic 13, 2023$0,60USD≈0.89%
Set 14, 2023$0,60USD≈0.90%
Giu 15, 2023$0,60USD≈0.81%
Mar 16, 2023$0,60USD≈0.90%
Dic 13, 2022$0,56USD≈0.92%
Set 15, 2022$0,56USD≈1.0%
Giu 15, 2022$0,56USD≈1.1%
Mar 16, 2022$0,56USD≈0.75%
Dic 13, 2021$0,48USD≈0.90%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media 7.9%
Prossimo report Ott 22, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Lug 23, 2026 $7.62 $7.54 1.0%
31 Marzo 2026 $7.15 $7.21 -0.85%
31 Dicembre 2025 $8.14 $7.53 8.0%
30 Settembre 2025 $6.96 $5.77 20.6%
30 Giugno 2025 $6.83 $6.31 8.2%
31 Marzo 2025 $6.45 $5.84 10.5%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 12
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A Expense $548M$421M$353M$307M$337M$416M$370M$344M$340M$343M
Operating Expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest Expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pretax Income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income Tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946M$1.64B$1.38B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Basic) $28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53
EPS (Diluted) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Shares (Basic) 236,413,000258,603,000272,404,000290,348,000323,315,000338,274,000341,210,000347,297,000362,305,000383,591,000
Shares (Diluted) 239,495,000261,806,000276,412,000294,666,000328,752,000343,605,000348,226,000355,303,000372,221,000395,851,000
EBITDA $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stato Patrimoniale 22
Metrica Tendenza 2025202420232022202120202019201820172016
Cash & Equivalents $1.04B$1.93B$935M$908M$1.45B$1.79B$621M$502M$732M$646M
Short-term Investments ·····$116M$147M$47M$54M$49M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Other Current Assets $2.22B$1.99B$2.01B$1.78B$2.01B$1.46B$1.35B$1.19B$1.17B$1.11B
Current Assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
PP&E (Net) $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
PP&E (Gross) $66.28B$62.51B$58.55B$54.76B$51.35B$49.32B$47.23B$42.97B$40.08B$37.05B
Accum. Depreciation $35.13B$33.10B$30.83B$29.18B$27.29B$26.12B$24.52B$23.21B$22.19B$20.70B
Other Non-current Assets $255M$230M$184M$298M$598M$546M$480M$690M$710M$1.07B
Total Assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts Payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Current Liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Capital Leases $1.85B$1.86B$1.90B$1.75B$1.75B$1.67B$1.50B···
Total Liabilities ······$45.62B$42.12B$41.59B$39.39B
Long-term Debt $44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Total Debt $41.60B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Retained Earnings $-5.72B$-2.12B$-1.35B$-2.28B$-532M$777M$-2.35B$-4.57B$-6.53B$-6.97B
AOCI $-305M$-387M$-425M$-490M$-404M$-502M$-460M$-381M$-278M$-338M
Stockholders' Equity $-6.03B$-2.50B$-1.77B$-2.77B$-933M$572M$-2.81B$-4.95B$-6.81B$-7.30B
Liabilities + Equity $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Shares Outstanding 224,605,100249,981,400265,537,300277,378,300305,476,800339,425,600338,445,600342,895,200350,091,600370,535,900
Flusso di cassa 17
Metrica Tendenza 2025202420232022202120202019201820172016
D&A $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based Comp $401M$360M$262M$341M$440M$362M$347M$268M$270M$251M
Amort. of Intangibles $12M$16M$20M$44M$25M$26M····
Other Non-cash $1.93B$1.08B$850M$-431M$-1.29B$2.40B$1.07B$461M$-3.53B$-2.67B
Operating Cash Flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
CapEx $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing Cash Flow $-4.99B$-4.93B$-5.32B$-3.39B$-2.64B$-3.39B$-5.72B$-3.90B$-4.28B$-3.24B
Debt Issued $8.47B$7.50B$3.22B$6.00B$4.34B$2.70B$6.45B$2.00B$1.50B$5.40B
Net Debt Issued $1.08B$5.08B$2.31B$3.17B$475M$-737M$1.13B$296M$749M$925M
Stock Repurchased $10.07B$6.04B$3.81B$7.00B$8.21B$441M$1.03B$1.53B$2.05B$2.75B
Net Stock Activity $-10.07B$-6.04B$-3.81B$-7.00B$-8.21B$-441M$-1.03B$-1.53B$-2.05B$-2.75B
Dividends Paid $679M$690M$661M$653M$624M$153M$550M$487M$0·
Financing Cash Flow $-8.55B$-4.58B$-4.09B$-5.66B$-6.66B$-4.68B$-1.77B$-3.08B$-1.06B$-2.51B
Net Change in Cash $-893M$998M$27M$-543M$-342M$1.17B$119M$-230M$86M$-95M
Taxes Paid $1.74B$1.84B$1.39B$1.18B$2.18B$1.00B$849M$872M$1.21B$1.25B
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Levered FCF $5.91B$4.03B$3.16B$2.74B$4.15B$5.12B$2.00B$1.74B$1.35B$1.68B
Redditività 5
Metrica Tendenza 2025202420232022202120202019201820172016
Net Margin 9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%··
Pretax Margin 13.0%12.1%11.9%14.2%16.7%10.5%10.2%11.4%··
EBITDA Margin 4.7%4.7%4.7%4.9%4.9%5.3%5.1%4.9%··
ROA 11.3%10.0%9.7%10.9%14.2%8.1%8.3%10.0%6.3%8.7%
ROE -159.1%-269.6%-230.9%-305.0%-3853.7%-335.8%-90.4%-64.4%-31.4%-38.8%
Liquidità e Solvibilità 4
Metrica Tendenza 2025202420232022202120202019201820172016
Current Ratio 1.01.11.21.41.41.41.41.31.61.6
Quick Ratio 0.70.80.91.01.01.01.11.01.21.1
Debt / Equity -6.9-17.2-22.3-13.8-37.154.2-12.0-6.6-4.9-4.3
LT Debt / Equity -6.9-15.3-21.0-13.6-36.853.8-12.0-6.5-4.8-4.3
Efficienza 2
Metrica Tendenza 2025202420232022202120202019201820172016
Asset Turnover 1.31.21.21.21.21.11.21.2··
Receivables Turnover 7.06.86.97.17.87.17.27.0··
Per Azione 6
Metrica Tendenza 2025202420232022202120202019201820172016
Book Value / Share $-26.83$-10.00$-6.68$-9.98$-3.05$1.69$-8.30$-14.44$-19.44$-19.71
Revenue / Share $315.66$269.68$235.04$204.41$178.71$149.98$147.42$131.37··
Cash Flow / Share $52.76$40.16$34.12$28.92$27.25$26.87$21.83$19.03$14.58$14.28
Cash / Share $4.63$7.73$3.52$3.27$4.75$5.28$1.83$1.46$2.09$1.74
Dividend / Share $2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40··
EPS (TTM) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Tassi di Crescita 10
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue YoY 7.1%8.7%7.9%2.5%14.0%·····
Revenue CAGR 3Y 7.9%6.3%8.0%·······
Revenue CAGR 5Y 8.0%·········
EPS YoY 28.8%16.0%-0.94%-9.5%93.6%·····
EPS CAGR 3Y 13.9%1.3%20.2%·······
EPS CAGR 5Y 21.0%·········
Net Income YoY 17.8%9.9%-7.1%-18.9%85.3%·····
Net Income CAGR 3Y 6.3%-6.1%11.8%·······
Net Income CAGR 5Y 12.6%·········
Dividends Paid CAGR 5Y 34.7%·········
Valutazione (TTM) 17
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue TTM $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Net Income TTM $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
Market Cap $104.86B$75.03B$71.88B$66.56B$78.48B$55.82B$50.03B$42.67B$30.75B$27.43B
Enterprise Value $145.42B$116.13B$110.53B$103.74B$111.61B$84.92B$82.98B$74.95B$63.02B$58.11B
P/E 16.513.614.312.512.115.014.711.714.810.1
P/S 1.41.11.11.11.31.11.00.90.70.7
P/B -17.4-30.0-40.5-24.1-84.197.6-17.8-8.6-4.5-3.8
P / Tangible Book ·····97.6····
P / Cash Flow 8.37.17.67.88.86.06.66.35.74.9
P / FCF 13.613.315.316.114.68.714.513.412.89.5
EV / EBITDA 41.335.135.934.939.131.232.032.929.629.6
EV / FCF 18.920.623.625.120.713.324.123.526.120.1
EV / Revenue 1.91.61.71.71.91.61.61.61.41.4
Dividend Yield 0.65%0.92%0.92%0.98%0.80%0.27%1.1%1.1%0.00%·
Earnings Yield 6.1%7.3%7.0%8.0%8.2%6.7%6.8%8.6%6.8%9.9%
Payout Ratio 10.0%12.0%12.6%11.6%9.0%4.1%15.7%12.9%··
Annual Payout $679M$690M$661M$653M$624M$153M$550M$487M$0·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $75.60B $70.60B $64.97B $60.23B $58.75B
Utile netto $6.78B $5.76B $5.24B $5.64B $6.96B
EPS Diluito $28.33 $22.00 $18.97 $19.15 $21.16

Proprietari istituzionali (13F) 1.474 filer · $57.2B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 1.474
Valore detenuto $57.2B
Nuove posizioni 121
Posizioni chiuse 176
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
121 (-64 vs trimestre precedente) 176 (+72 vs trimestre precedente) 458 (-25 vs trimestre precedente) 581 (+4 vs trimestre precedente) -627K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD GROUP INC $6.870.392.526 14.716.173 12,00% Azioni
BlackRock, Inc. $5.069.973.824 13.003.600 8,86% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $3.954.150.533 10.141.708 6,91% Azioni
Sanders Capital, LLC $3.442.060.818 8.828.287 6,01% Azioni
STATE STREET CORP $2.912.102.056 7.469.035 5,09% Azioni
WELLINGTON MANAGEMENT GROUP LLP $1.835.396.649 4.707.473 3,21% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.423.654.808 3.668.008 2,49% Azioni
First Eagle Investment Management, LLC $1.284.907.912 3.295.565 2,24% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $1.057.704.509 2.712.828 1,85% Azioni
MORGAN STANLEY $1.008.556.857 2.586.771 1,76% Azioni
GOLDMAN SACHS GROUP INC $960.811.481 2.464.314 1,68% Azioni
JPMORGAN CHASE & CO $896.800.955 2.285.832 1,57% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861.456.107 2.209.485 1,50% Azioni
NORGES BANK $836.457.140 2.145.367 1,46% Azioni
Capital World Investors $770.864.224 1.977.121 1,35% Azioni
Capital International Investors $747.403.041 1.916.947 1,31% Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $709.859.997 1.500.000 1,24% Azioni
NORTHERN TRUST CORP $666.150.458 1.708.560 1,16% Azioni
FMR LLC $636.503.475 1.632.520 1,11% Azioni
Invesco Ltd. $596.390.232 1.529.637 1,04% Azioni
NORDEA INVESTMENT MANAGEMENT AB $553.702.529 1.429.943 0,97% Azioni
BARCLAYS PLC $514.349.127 1.319.216 0,90% Azioni
JANUS HENDERSON GROUP PLC $481.486.890 1.017.441 0,84% Azioni
Crake Asset Management LLP $449.072.183 1.151.792 0,78% Azioni
Metropolis Capital Ltd $430.915.307 910.564 0,75% Azioni
Darsana Capital Partners LP $428.879.000 1.100.000 0,75% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414.565.358 1.063.288 0,72% Azioni
Legal & General Group Plc $410.992.402 1.054.124 0,72% Azioni
FRANKLIN RESOURCES INC $399.958.688 1.025.824 0,70% Azioni
Life Cycle Investment Partners Ltd $355.737.196 912.404 0,62% Azioni
Bank of New York Mellon Corp $350.359.895 898.612 0,61% Azioni
VANGUARD FIDUCIARY TRUST CO $339.685.814 871.235 0,59% Azioni
ROYAL BANK OF CANADA $320.194.000 821.241 0,56% Azioni
LYRICAL ASSET MANAGEMENT LP $255.015.742 654.071 0,45% Azioni
BANK OF AMERICA CORP /DE/ $238.456.934 611.601 0,42% Azioni
SCHRODER INVESTMENT MANAGEMENT GROUP $237.236.367 608.470 0,41% Azioni
ROYAL LONDON ASSET MANAGEMENT LTD $235.649.908 604.401 0,41% Azioni
PRINCIPAL FINANCIAL GROUP INC $234.827.401 602.290 0,41% Azioni
UBS Group AG $230.953.291 592.355 0,40% Azioni
National Pension Service $230.650.346 591.578 0,40% Azioni
Russell Investments Group, Ltd. $206.832.565 530.340 0,36% Azioni
Nuveen, LLC $199.595.109 511.927 0,35% Azioni
Gobi Capital LLC $195.742.325 502.045 0,34% Azioni
Cryder Capital Partners LLP $194.561.738 499.017 0,34% Azioni
Allianz Asset Management GmbH $181.127.299 464.560 0,32% Azioni
DEUTSCHE BANK AG\ $175.985.429 451.372 0,31% Azioni
Swiss National Bank $172.097.446 441.400 0,30% Azioni
DIMENSIONAL FUND ADVISORS LP $172.079.393 441.313 0,30% Azioni
AustralianSuper Pty Ltd $159.635.782 409.438 0,28% Azioni
HSBC HOLDINGS PLC $158.555.065 406.750 0,28% Azioni

Mostra tutti i 1.474 proprietari istituzionali →

Attivisti e proprietari del 5%+ 4 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 Febbraio 2026 31,60% Deposito iniziale · SEC
22 Novembre 2006 · Deposito iniziale · SEC
Merrill Lynch Bank USA 11 Settembre 2006 · Deposito iniziale · SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 04 Agosto 2006 · Deposito iniziale · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 92 insider · 54 dirigenti · 31 direttori

19
Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Samuel N Hazen CEO 10 Febbraio 2026 F 64.842 0 7 $-21.483.290
O'Boyle Michael P President & CEO - Parallon 26 Febbraio 2013 A 21.429 0 0 $0
Mike A Marks EVP and CFO 07 Maggio 2026 G 46.576 0 0 $0
Bill B Rutherford CFO and EVP 16 Febbraio 2024 F 22.251 0 0 $0
Russell K Harms CFO - Central Group 17 Novembre 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 Novembre 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 Novembre 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 01 Luglio 2005 F 13.865 0 0 $0
Erol R Akdamar Group President 12 Novembre 2024 M 6.843 0 0 $0
Timothy M Mcmanus Group President 31 Luglio 2024 M 27.008 0 0 $0
Richard A Hammett Group President 16 Febbraio 2024 F 17.936 0 0 $0
Charles J Hall Group President 11 Novembre 2022 M 202.443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 Novembre 2022 S 30.807 0 0 $0
Paul W Rutledge Group President 31 Dicembre 2012 A 335.657 0 0 $0
Beverly B Wallace President - Parallon 02 Novembre 2011 M 144.714 0 0 $0
Charles Robert Evans President - Eastern Group 26 Luglio 2006 A 62.173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 Ottobre 2005 A 26.154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 Ottobre 2004 D 9.029 0 0 $0
Jay Grinney President-Eastern Group 07 Maggio 2004 D 24.177 0 0 $0
Jon M Foster EVP and COO 10 Febbraio 2026 F 23.062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 26 Agosto 2026 J 0 0 2 $-2.747.520
Jennifer Berres SVP & Chief Human Res. Officer 11 Febbraio 2026 S 11.993 0 2 $-4.126.932
Christopher F. Wyatt SVP & Controller 11 Febbraio 2026 S 44.379 0 1 $-2.020.000
Erica Rossitto SVP & Chief Nurse Executive 10 Febbraio 2026 F 10.407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 Febbraio 2026 F 32.080 0 1 $-747.135
Sammie S Mosier SVP & Chief Nurse Executive 13 Febbraio 2025 F 11.113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 Novembre 2024 S 9.454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 Novembre 2024 M 52.702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 05 Agosto 2024 G 18.526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 Luglio 2024 S 3.510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 Luglio 2024 S 17.755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 09 Maggio 2024 S 5.185 0 0 $0
Chad J Wasserman SVP and CIO 18 Marzo 2024 M 1.576 0 0 $0
Martin P. Paslick SVP and CIO 12 Aprile 2023 M 24.643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 09 Novembre 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 05 Maggio 2021 S 50.062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 Febbraio 2021 F 5.578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 Febbraio 2021 F 10.122 0 0 $0
Victor L Campbell SVP-Government Affairs 01 Maggio 2019 A 194.145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 Febbraio 2019 M 84.157 0 0 $0
Milton R Johnson Chairman 25 Febbraio 2019 M 881.823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 Febbraio 2018 M 7.003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 Febbraio 2018 M 35.546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 Febbraio 2018 M 65.199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 Maggio 2017 M 26.378 0 0 $0
David Gwin Anderson SVP - Finance 07 Novembre 2016 M 110.167 0 0 $0
Donald W Stinnett SVP & Controller 25 Febbraio 2016 A 51.965 0 0 $0
Noel B Williams SVP and CIO 16 Maggio 2012 M 299.030 0 0 $0
Jack O Bovender JR Chairman 06 Ottobre 2009 A 188.340 0 0 $0
Carl V George SVP - Development 27 Febbraio 2009 M 13.092 0 0 $0
Patricia T Lindler SVP - Government Programs 17 Novembre 2006 D 0 0 0 $0
Rosalyn S Elton SVP-Operations Finance 17 Novembre 2006 D 0 0 0 $0
Frank M Houser MD SVP-Quality & Medical Director 26 Luglio 2006 A 46.145 0 0 $0
James A Fitzgerald JR SVP-Supply Chain Operations 29 Gennaio 2006 F 20.674 0 0 $0
Andrea B Smith Direttore 28 Aprile 2026 A 4.666 0 0 $0
William R Frist Direttore 28 Aprile 2026 A 13.740 0 0 $0
Wayne Joseph Riley Direttore 28 Aprile 2026 A 15.029 0 0 $0
Hugh F Johnston Direttore 28 Aprile 2026 A 4.475 0 0 $0
Thomas F Frist III Direttore 28 Aprile 2026 A 15.858 0 0 $0
Michael W Michelson Direttore 28 Aprile 2026 A 12.576 0 0 $0
Nancy Ann Deparle Direttore 28 Aprile 2026 A 21.910 0 0 $0
John Chidsey Direttore 28 Aprile 2026 A 1.305 0 0 $0
Robert J Dennis Direttore 29 Aprile 2025 A 26.601 0 0 $0
Meg Crofton Direttore 29 Aprile 2024 A 6.331 0 0 $0
Charles O Holliday JR Direttore 25 Aprile 2022 A 18.955 0 0 $0
Geoffrey G Meyers Direttore 01 Maggio 2019 A 39.153 0 0 $0
John W Rowe Direttore 01 Maggio 2019 A 30.388 0 0 $0
Ann H Lamont Direttore 02 Maggio 2018 A 17.661 0 0 $0
Jay O Light Direttore 03 Maggio 2017 A 30.953 0 0 $0
Stephen G Pagliuca Direttore 05 Dicembre 2014 D 7.612.921 0 0 $0
Christopher R Gordon Direttore 01 Novembre 2013 D 30.003.156 0 0 $0
John Connaughton Direttore 01 Novembre 2013 D 30.003.156 0 0 $0
John H Mcarthur Direttore 17 Novembre 2006 D 0 0 0 $0
Kent C Nelson Direttore 17 Novembre 2006 D 0 0 0 $0
Magdalena Averhoff MD Direttore 17 Novembre 2006 D 0 0 0 $0
Glenda A Hatchett Direttore 17 Novembre 2006 D 0 0 0 $0
Frederick W Gluck Direttore 17 Novembre 2006 D 0 0 0 $0
Harold T Shapiro Direttore 17 Novembre 2006 D 0 0 0 $0
Michael C Armstrong Direttore 17 Novembre 2006 D 0 0 0 $0
Martin Feldstein Direttore 17 Novembre 2006 D 0 0 0 $0
Michael T Long Direttore 17 Novembre 2006 D 0 0 0 $0
ROYAL FRANK S Direttore 17 Novembre 2006 D 0 0 0 $0
Patricia F Elcan Proprietario del 10% 06 Febbraio 2026 J 36.557.141 0 0 $0
Frisco Holding II Proprietario del 10% 06 Febbraio 2026 J 36.557.141 0 0 $0
HERCULES HOLDING II, LLC Proprietario del 10% 06 Febbraio 2026 J 32.282.889 0 0 $0
Thomas F Frist JR Proprietario del 10% 06 Febbraio 2026 J 36.557.141 0 0 $0
Patricia C Frist Proprietario del 10% 20 Febbraio 2018 G 0 0 0 $0
KKR PEI GP LTD Proprietario del 10% 01 Aprile 2014 J 0 0 0 $0
Jonathan B Perlin · 02 Agosto 2021 S 44.348 0 0 $0
Juan Vallarino · 09 Maggio 2016 M 61.036 0 0 $0
Richard M Bracken · 31 Dicembre 2014 F 82.499 0 0 $0
BANK OF AMERICA CORP /DE/ · 06 Novembre 2012 S 2.652.364 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 141 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
BUL · Pacer Funds Trust 5,07% 16.545 NS 31 Luglio 2026 N-PORT
IHF · iShares Trust 4,75% 147.977 SH 11 Settembre 2026 Giornaliero
STNC · Hennessy Funds Trust 3,17% 7.315 NS 31 Luglio 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,47% 97.151 SH 05 Ottobre 2026 Giornaliero
COWZ · Pacer Funds Trust 2,07% 960.711 NS 31 Luglio 2026 N-PORT
WLTG · ETF Opportunities Trust 2,06% 3.942 NS 31 Luglio 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 34.181 SH 05 Ottobre 2026 Giornaliero
RPG · Invesco Exchange-Traded Fund Trust 1,27% 58.310 SH 05 Ottobre 2026 Giornaliero
FLAG · Global X Funds 1,14% 48 NS 31 Luglio 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,03% 6.909 NS 31 Luglio 2026 N-PORT
IYH · iShares Trust 1,01% 87.417 SH 11 Settembre 2026 Giornaliero
SRHQ · Elevation Series Trust 0,94% 4.938 NS 31 Luglio 2026 N-PORT
NEAR · iShares U.S. ETF Trust 0,92% 48.109.000 SH 11 Settembre 2026 Giornaliero
FHLC · FIDELITY COVINGTON TRUST 0,91% 74.445 NS 31 Luglio 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470.451 SH 19 Agosto 2026 Giornaliero
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 22.725 NS 31 Luglio 2026 N-PORT
DIVB · iShares Trust 0,87% 42.100 SH 11 Settembre 2026 Giornaliero
NFRA · FlexShares Trust 0,84% 62.628 NS 31 Luglio 2026 N-PORT
IXJ · iShares Trust 0,83% 81.708 SH 11 Settembre 2026 Giornaliero
SPVM · Invesco Exchange-Traded Fund Trust 0,80% 2.483 SH 05 Ottobre 2026 Giornaliero
QUVU · Hartford Funds Exchange-Traded Trust 0,79% 3.522 NS 31 Luglio 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,78% 23.458.000 05 Ottobre 2026 Giornaliero
BSCS · Invesco Exchange-Traded Self-Indexe… 0,74% 25.787.000 05 Ottobre 2026 Giornaliero
CURE · Direxion Shares ETF Trust 0,72% 3.056 NS 31 Luglio 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12.075 SH 19 Agosto 2026 Giornaliero
LGDX · Tidal Trust III 0,66% 2.345 NS 31 Luglio 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11.876 SH 19 Agosto 2026 Giornaliero
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22.854.000 05 Ottobre 2026 Giornaliero
LSVD · ADVISORS' INNER CIRCLE FUND 0,46% 7.404 NS 31 Luglio 2026 N-PORT
WLDR · Two Roads Shared Trust 0,43% 964 NS 31 Luglio 2026 N-PORT
ROUS · Lattice Strategies Trust 0,42% 7.289 NS 31 Luglio 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,40% 92.347 SH 05 Ottobre 2026 Giornaliero
QLC · FlexShares Trust 0,39% 9.856 NS 31 Luglio 2026 N-PORT
XOEF · iShares Trust 0,37% 194 SH 11 Settembre 2026 Giornaliero
GSY · Invesco Actively Managed Exchange-T… 0,36% 14.000.000 05 Ottobre 2026 Giornaliero
UPSD · ETF Series Solutions 0,33% 972 NS 31 Luglio 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,33% 9.324.000 05 Ottobre 2026 Giornaliero
MGV · VANGUARD WORLD FUND 0,29% 97.604 SH 19 Agosto 2026 Giornaliero
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 390.000 02 Ottobre 2026 Giornaliero
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,28% 3.186 NS 31 Luglio 2026 N-PORT
USXF · iShares Trust 0,26% 9.226 SH 11 Settembre 2026 Giornaliero
IUS · Invesco Exchange-Traded Self-Indexe… 0,26% 5.813 SH 05 Ottobre 2026 Giornaliero
IWX · iShares Trust 0,23% 21.535 SH 11 Settembre 2026 Giornaliero
VTV · VANGUARD INDEX FUNDS 0,23% 1.475.731 SH 19 Agosto 2026 Giornaliero
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 14.235 NS 31 Luglio 2026 N-PORT
MPLY · Strategy Shares 0,22% 87 NS 31 Luglio 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9.589 SH 11 Settembre 2026 Giornaliero
RSP · Invesco Exchange-Traded Fund Trust 0,21% 461.214 SH 05 Ottobre 2026 Giornaliero
FTC · First Trust Exchange-Traded AlphaDE… 0,20% 6.420 NS 31 Luglio 2026 N-PORT
SIZE · iShares Trust 0,19% 1.920 SH 11 Settembre 2026 Giornaliero
DYNF · BlackRock ETF Trust 0,19% 183.934 SH 11 Settembre 2026 Giornaliero
VMAX · Lattice Strategies Trust 0,19% 228 NS 31 Luglio 2026 N-PORT
DSI · iShares Trust 0,19% 23.734 SH 11 Settembre 2026 Giornaliero
ILCV · iShares Trust 0,18% 5.870 SH 10 Settembre 2026 Giornaliero
IVW · iShares Trust 0,18% 331.185 SH 11 Settembre 2026 Giornaliero
IUSG · iShares Trust 0,17% 136.713 SH 11 Settembre 2026 Giornaliero
VOOG · VANGUARD ADMIRAL FUNDS 0,17% 115.334 SH 19 Agosto 2026 Giornaliero
IWD · iShares Trust 0,17% 332.035 SH 11 Settembre 2026 Giornaliero
VONV · VANGUARD SCOTTSDALE FUNDS 0,16% 90.157 SH 19 Agosto 2026 Giornaliero
OMFL · Invesco Exchange-Traded Self-Indexe… 0,16% 17.773 SH 05 Ottobre 2026 Giornaliero
USMV · iShares Trust 0,16% 89.855 SH 11 Settembre 2026 Giornaliero
ACWV · iShares, Inc. 0,15% 11.903 SH 11 Settembre 2026 Giornaliero
EGLE · Global X Funds 0,15% 8 NS 31 Luglio 2026 N-PORT
GLBL · Pacer Funds Trust 0,15% 4 NS 31 Luglio 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,14% 33.331 SH 05 Ottobre 2026 Giornaliero
VOXP · Advisors Series Trust 0,13% 18 NS 31 Luglio 2026 N-PORT
VRIG · Invesco Actively Managed Exchange-T… 0,12% 2.250.000 01 Ottobre 2026 Giornaliero
TOPC · iShares Trust 0,12% 95 SH 11 Settembre 2026 Giornaliero
DGRO · iShares Trust 0,12% 120.741 SH 11 Settembre 2026 Giornaliero
XVV · iShares Trust 0,11% 1.790 SH 11 Settembre 2026 Giornaliero
QVML · Invesco Exchange-Traded Fund Trust … 0,11% 4.428 SH 05 Ottobre 2026 Giornaliero
IWL · iShares Trust 0,11% 5.786 SH 11 Settembre 2026 Giornaliero
MGC · VANGUARD WORLD FUND 0,11% 31.176 SH 19 Agosto 2026 Giornaliero
ACIO · ETF Series Solutions 0,11% 6.205 NS 31 Luglio 2026 N-PORT
EVUS · iShares Trust 0,10% 934 SH 11 Settembre 2026 Giornaliero
ADME · ETF Series Solutions 0,10% 751 NS 31 Luglio 2026 N-PORT
XRMI · Global X Funds 0,10% 126 NS 31 Luglio 2026 N-PORT
XCLR · Global X Funds 0,10% 9 NS 31 Luglio 2026 N-PORT
XYLD · Global X Funds 0,10% 8.148 NS 31 Luglio 2026 N-PORT
XTR · Global X Funds 0,10% 12 NS 31 Luglio 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,10% 13.621 NS 31 Luglio 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,10% 25.167 SH 05 Ottobre 2026 Giornaliero
VV · VANGUARD INDEX FUNDS 0,10% 181.364 SH 19 Agosto 2026 Giornaliero
ESGV · VANGUARD WORLD FUND 0,10% 33.758 SH 19 Agosto 2026 Giornaliero
IVV · iShares Trust 0,10% 1.957.485 SH 11 Settembre 2026 Giornaliero
PTLC · Pacer Funds Trust 0,10% 7.919 NS 31 Luglio 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,10% 1.395 NS 31 Luglio 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,10% 877 SH 05 Ottobre 2026 Giornaliero
ILCB · iShares Trust 0,10% 2.915 SH 11 Settembre 2026 Giornaliero
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 1.794 SH 02 Ottobre 2026 Giornaliero
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,09% 20.766 NS 31 Luglio 2026 N-PORT
IYY · iShares Trust 0,09% 6.693 SH 11 Settembre 2026 Giornaliero
VOTE · TCW ETF Trust 0,09% 2.545 NS 31 Luglio 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,09% 3.614 NS 31 Luglio 2026 N-PORT
XYLG · Global X Funds 0,09% 147 NS 31 Luglio 2026 N-PORT
DFUS · Dimensional ETF Trust 0,09% 46.791 NS 31 Luglio 2026 N-PORT
IWB · iShares Trust 0,09% 103.721 SH 11 Settembre 2026 Giornaliero
VOO · VANGUARD INDEX FUNDS 0,09% 4.034.357 SH 19 Agosto 2026 Giornaliero
TOV · EA Series Trust 0,09% 607 NS 31 Luglio 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,09% 586 NS 31 Luglio 2026 N-PORT
ITOT · iShares Trust 0,09% 202.387 SH 11 Settembre 2026 Giornaliero
ACVF · ETF Opportunities Trust 0,09% 337 NS 31 Luglio 2026 N-PORT
GTOS · Invesco Actively Managed Exchange-T… 0,09% 104.000 05 Ottobre 2026 Giornaliero
QDPL · Pacer Funds Trust 0,09% 3.708 NS 31 Luglio 2026 N-PORT
IWV · iShares Trust 0,09% 41.034 SH 11 Settembre 2026 Giornaliero
DFAU · Dimensional ETF Trust 0,08% 25.516 NS 31 Luglio 2026 N-PORT
CRBN · iShares Trust 0,08% 2.269 SH 11 Settembre 2026 Giornaliero
TOK · iShares Trust 0,08% 451 SH 11 Settembre 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,08% 4.930.930 SH 19 Agosto 2026 Giornaliero
VONE · VANGUARD SCOTTSDALE FUNDS 0,08% 24.633 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,08% 12.577 SH 19 Agosto 2026 Giornaliero
PHDG · Invesco Actively Managed Exchange-T… 0,08% 116 SH 05 Ottobre 2026 Giornaliero
HCMT · Direxion Shares ETF Trust 0,08% 1.081 NS 31 Luglio 2026 N-PORT
TILT · FlexShares Trust 0,08% 4.108 NS 31 Luglio 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,07% 12.141 NS 31 Luglio 2026 N-PORT
URTH · iShares, Inc. 0,07% 14.079 SH 11 Settembre 2026 Giornaliero
ACWI · iShares Trust 0,06% 50.294 SH 11 Settembre 2026 Giornaliero
HDUS · Lattice Strategies Trust 0,05% 275 NS 31 Luglio 2026 N-PORT
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,05% 125.729 SH 19 Agosto 2026 Giornaliero
DCOR · Dimensional ETF Trust 0,05% 3.816 NS 31 Luglio 2026 N-PORT
GLOF · iShares Trust 0,04% 202 SH 11 Settembre 2026 Giornaliero
DUHP · Dimensional ETF Trust 0,04% 10.761 NS 31 Luglio 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 28.662 NS 31 Luglio 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 1.127 NS 31 Luglio 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 99 NS 31 Luglio 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0,00% 42.000 30 Settembre 2026 Giornaliero
CBLS · Elevation Series Trust -1,12% -1.546 NS 31 Luglio 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BLV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BSV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BND · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VUSB · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VCRB · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VPLS · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VSDB · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
VCEB · VANGUARD WORLD FUND · · 30 Luglio 2026 Giornaliero

HCA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 30 analisti COMPRA
Target mediano $450.00 +4,1%
6 20,0% Acquisto forte
11 36,7% Compra
12 40,0% Mantieni
1 3,3% Vendi
0 0,0% Vendita forte

Target Price a 12 Mesi

22 analisti · 2026-10-05

Target medio $454.23 +5,1%

Ora Prezzo attuale $432.20
Basso$380.00 Media$454.23 Alto$579.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·
THC $17.28B 12.8 3.1% 11.1% 56.4% ·
EHC $10.61B 19.2 10.5% 9.5% 25.1% ·
UHS · 9.4 9.7% 8.6% 21.4% ·
ENSG $10.12B 29.8 18.7% 6.8% 16.9% ·
PACS $6.01B 31.5 29.3% 3.6% 23.1% ·
CON $2.53B 15.1 13.9% 7.7% 49.8% ·
ACHC $1.28B -1.2 5.0% -33.3% -43.9% ·
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
SNDA $612M -7.7 25.2% -18.6% -197.2% ·

Ultime notizie Notizie recenti che menzionano questa società

23

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

25

Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 10-Q depositato Lug 28, 2026